0001437749-24-008707.txt : 20240320
0001437749-24-008707.hdr.sgml : 20240320
20240320163832
ACCESSION NUMBER: 0001437749-24-008707
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240318
FILED AS OF DATE: 20240320
DATE AS OF CHANGE: 20240320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schoenberg Mark
CENTRAL INDEX KEY: 0001763581
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38079
FILM NUMBER: 24768286
MAIL ADDRESS:
STREET 1: C/O UROGEN PHARMA LTD.
STREET 2: 9 HA TA ASIYA STREET
CITY: RA ANANA
STATE: L3
ZIP: 4365007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UroGen Pharma Ltd.
CENTRAL INDEX KEY: 0001668243
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
BUSINESS PHONE: 972 9 770 7601
MAIL ADDRESS:
STREET 1: 9 HA'TA'ASIYA ST
CITY: RA'ANANA
STATE: L3
ZIP: 4365007
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-03-18
0001668243
UroGen Pharma Ltd.
URGN
0001763581
Schoenberg Mark
400 ALEXANDER PARK DRIVE
PRINCETON
NJ
08540
1
Chief Medical Officer
0
Ordinary Shares
2024-03-18
4
S
0
12000
14.05
D
139437
D
A portion of the cash receipts will be used for federal income tax purposes
/s/ Jason D. Smith, Attorney-in-Fact
2024-03-20